The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
暂无分享,去创建一个
S. Akira | T. Kawai | H. Young | H. Kumar | S. Vogel | K. Fitzgerald | N. Goutagny | H. Kato | Z. Roberts | P. Perera | R. Savan | D. V. Van Echo | L. Ching